NCT04208698View on ClinicalTrials.gov

A Scintigraphy Study in Adults With Diabetic Gastroparesis

PHASE2TerminatedINTERVENTIONAL
Enrollment

2

Participants

Timeline

Start Date

February 17, 2020

Primary Completion Date

March 31, 2020

Study Completion Date

March 31, 2020

Conditions
Diabetic Gastroparesis
Interventions
DRUG

CIN-102 Dose 1

Deuterated domperidone (deudomperidone)

DRUG

CIN-102 Dose 2

Deuterated domperidone (deudomperidone)

DRUG

Placebo for CIN-102

Placebo

Trial Locations (1)

79905

Research Site, El Paso

Sponsors
All Listed Sponsors
lead

CinDome Pharma, Inc.

INDUSTRY